Elevation Oncology, Inc. (NASDAQ:ELEV – Get Free Report) was the recipient of a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 4,630,000 shares, an increase of 28.3% from the February 29th total of 3,610,000 shares. Approximately 11.6% of the company’s shares are sold short. […]
Elevation Oncology, Inc. (NASDAQ:ELEV – Free Report) – Stock analysts at Wedbush upped their Q1 2024 EPS estimates for shares of Elevation Oncology in a research note issued on Wednesday, March 6th. Wedbush analyst R. Driscoll now expects that the company will earn ($0.19) per share for the quarter, up from their previous forecast of […]
Elevation Oncology, Inc. (NASDAQ:ELEV – Free Report) – Research analysts at Leerink Partnrs raised their Q1 2024 earnings per share (EPS) estimates for shares of Elevation Oncology in a note issued to investors on Wednesday, March 6th. Leerink Partnrs analyst A. Berens now anticipates that the company will earn ($0.23) per share for the quarter, […]
Elevation Oncology, Inc. (NASDAQ:ELEV – Free Report) – Investment analysts at HC Wainwright upped their Q1 2024 EPS estimates for Elevation Oncology in a research report issued to clients and investors on Thursday, March 7th. HC Wainwright analyst S. Ramakanth now forecasts that the company will earn ($0.20) per share for the quarter, up from […]